The resignation of Dr. Peter Marks, the FDA's top vaccine official, led to significant drops in the stock prices of major vaccine makers like Moderna and Pfizer. Marks cited conflicts with HHS Secretary RFK Jr., known for his anti-vaccine stance, in his resignation letter, expressing concerns over prioritizing misinformation. This departure has raised alarms on Wall Street about the potential implications for drug approval processes and overall safety within the biotech sector, which is already under pressure from broader market challenges.
"It has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies," Marks wrote in his resignation letter.
Analysts are expressing concern over how the situation might affect the biotech industry, questioning if the move will hamper the FDA's ability to ensure safe and effective treatments.
Collection
[
|
...
]